Search results
CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids...
Digital Journal· 15 hours agoAnnounces $5 Million Regulation Crowdfunding Offering Obsidian Energy Announces First Quarter 2024 Results More from Digital Journal Let’s waltz! Vienna ball season back in ...
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board
CBS 47 Fresno· 18 hours agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology ...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at...
CBS 47 Fresno· 18 hours agoAcurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat ...
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion...
Fortune via Yahoo Finance· 1 day agoJ&J also agreed to pay $700 million to 42 states and Washington, D.C., to settle a probe into the...
What is behind the insulin shortage in the US?
Al Jazeera· 13 hours agoSkye Murphy, who is 22 years old, has lived with type 1 diabetes since she was 14. In the past month, she learned that there would be a 30-to-60-day...
X4 Pharmaceuticals’ bet on drug for ultra-rare disease pays off with FDA approval - Boston Business ...
The Business Journals· 4 days agoA Boston biotech has received FDA approval for the first approved treatment specifically for...
The Petri Dish: M&A continues to heat up in Mass. life sciences - Boston Business Journal
The Business Journals· 20 hours agoMergers and acquisitions continue to heat up in Massachusetts after a slowdown over the past couple...
Study assesses health care providers' knowledge, attitudes, perception regarding Halal ...
Medical Xpress· 2 days agoThe way religious beliefs and medical treatments intersect can really affect how people use...
At Biogen, CEO Viehbacher got less total pay than many executives last year - Boston Business ...
The Business Journals· 3 days agoWhen Christopher Viehbacher became CEO of Biogen Inc. in late 2022, he landed $30.5 million in total...
Ultragenyx: Q1 Earnings Snapshot
San Mateo Daily Journal· 9 hours agoNOVATO, Calif. (AP) — NOVATO, Calif. (AP) — Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $170.7 million in its first quarter.
